Uroplasty (NASDAQ:UPI) has obtained additional insurance reimbursement for its Urgent PC Neuromodulation System, the company announced today. NHIC Corp., the Medicare company for Maine, Massachusetts, New Hampshire, Rhode Island and Vermont, will provide reimbursement for Uroplasty’s Urgent PC Neuromodulation System effective May 22, 2011. NHIC covers about 1.8 million individuals.
NHIC had previously provided some reimbursement for Uroplasty’s posterior tibial nerve stimulation treatments on a case-by-case basis.
This decision follows on the heels of Uroplasty’s recently obtained coverage by national insurance company UnitedHealthcare and regional insurer Excellus BlueCross BlueShield, as well as regional Medicare carrier CIGNA Government Services.
Why is Athersys suddenly hyping its preclinical obesity drug?
MDT to cut 1,000 in slowing markets; 1,500 to be added mainly overseas
Novo Nordisk gets FDA approval to expand type1 diabetes drug to young children
Firm enabling healthy aging raising $13 million from strategic investors
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Merrill GooznerPharma, device firms kill conflict of interest rule, win accelerated approval
Dr. John D. HalamkaBYOD makes mobile security more complicated
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Amy SiegelTop 5 anxiety-provoking medtech acronyms
Stephen Schimpff MDIntegrative Medicine Part II — Health Care of the Future
John Mandrola, MDWeighing the risks of Pradaxa vs. the risk of stroke
Comments
Post a comment
No comments yet.
Post a Comment